Rosenberg, ScD, led a survey that found women who have double mastectomies
generally overestimate their likelihood of getting cancer in the healthy
E. Krop led a study showing that the anti-body drug ado-trastuzumab emtansine
significantly prolonged progression-free survival in patients with progressive
HER2-positive advanced breast cancer.
Dr. Lisa Diller commented on the effects that childhood cancer treatment can have on adult survivors.
Tags: BasicResearch, EndOfLife
Tags: Disparities, PopulationScience
Tags: BasicResearch, ChildhoodCancer
Tags: BasicResearch, StemCellTransplant
Tags: BasicResearch, BreastCancer
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: